SUSQUEHANNA INTERNATIONAL GROUP, LLP - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 75 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$20,471,000
+175.6%
594,207
+33.7%
0.01%
+400.0%
Q2 2020$7,428,000
+28.3%
444,530
+10.7%
0.00%0.0%
Q1 2020$5,790,000
-43.7%
401,472
+30.6%
0.00%
-50.0%
Q4 2019$10,290,000
+15.8%
307,452
-27.6%
0.00%
-33.3%
Q3 2019$8,887,000
-14.7%
424,389
-15.2%
0.00%
+200.0%
Q2 2019$10,422,000
+157.8%
500,608
+176.8%
0.00%
-50.0%
Q1 2019$4,042,000
+42.1%
180,834
+52.1%
0.00%
+100.0%
Q4 2018$2,844,000
-44.8%
118,895
-37.1%
0.00%
-50.0%
Q3 2018$5,155,000
+13.7%
189,000
+12.1%
0.00%0.0%
Q2 2018$4,535,000
-77.9%
168,670
-73.8%
0.00%
-71.4%
Q1 2018$20,514,000
+289.9%
644,471
+363.3%
0.01%
+250.0%
Q4 2017$5,261,000
+10.7%
139,111
-27.4%
0.00%0.0%
Q3 2017$4,751,000
+2021.0%
191,664
+1658.4%
0.00%
Q2 2017$224,000
-5.5%
10,9000.0%0.00%
Q1 2017$237,000
-86.8%
10,900
-87.5%
0.00%
Q4 2016$1,790,000
+764.7%
87,494
+356.6%
0.00%
Q2 2016$207,000
-78.7%
19,164
-50.1%
0.00%
Q3 2015$972,00038,3730.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders